Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain

ClinicalTrials.gov ID: NCT00414466

Public ClinicalTrials.gov record NCT00414466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind, Placebo-controlled, Dose Response Study of Intraspinal Gabapentin (MDT2004) in Subjects With Chronic, Intractable Pain.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and minimum effective dose of intraspinal gabapentin when delivered through an implanted drug infusion system.

Study identification

NCT ID
NCT00414466
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedtronicNeuro
Industry
Enrollment
254 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2006
Primary completion
Nov 30, 2009
Completion
Jul 31, 2010
Last update posted
Aug 22, 2013

2006 – 2010

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Innovative Spine Care Little Rock Arkansas 72205
Napa Pain Institute Napa California 94558
Sarasota Pain Medicine Research Sarasota Florida 34238
WK River Cities Clinical Research Center Shreveport Louisiana 71105
MAPS Applied Research Center Edina Minnesota 55435
Mayo Clinic Rochester Minnesota 55905
U B Neurosurgery, Inc. Buffalo New York 14203
The Center for Clinical Research Winston-Salem North Carolina 27103
Pain Research of Oregon, LLC Eugene Oregon 97401
Oregon Health & Science University, Neurosurgery Department Portland Oregon 97201
Lehigh Valley Hospital Center for Pain Management Allentown Pennsylvania 18103
Pinnacle Pain Medicine Dallas Texas 75240
Axis Spine Care/Texas Spine & Joint Tyler Texas 75701
Lifetree Clinical Research Salt Lake City Utah 84106

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00414466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2013 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00414466 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →